NCT00271258View on ClinicalTrials.gov

Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

January 31, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

SODIUM DIVALPROATE

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00271258 - Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents | Biotech Hunter | Biotech Hunter